SCHEMBL2448488

SCHEMBL2448488

COc1ccc(Cl)cc1NC(=O)CN1CCc2nc3ccccc3c(C(=O)N3CCN(CCN4CCCCC4)CC3)c2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
MAPK1 P28482 2/20 0.54
POLB P06746 3/20 0.54
LMNA P02545 5/20 0.53
TP53 P04637 1/20 0.52
MAPT P10636 5/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
GAA P10253 1/20 0.48
THRB P10828 1/20 0.47
KCNT1 Q5JUK3 1/20 0.46
HTT P42858 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
KDM4E B2RXH2 1/20 0.45
TSHR P16473 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320298 0.94 POLB (0.53) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2320643 0.94 POLB (0.55) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL12301082 0.94 POLB (0.55) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2448301 0.93 POLB (0.59) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2315984 0.92 POLB (0.56) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2445191 0.92 ALDH1A1 (0.57) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2316555 0.92 POLB (0.53) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2451480 0.91 ALDH1A1 (0.58) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2323535 0.91 POLB (0.56) ALDH1A1MAPK1POLBLMNATP53
SCHEMBL2445262 0.89 POLB (0.53) ALDH1A1MAPK1POLBLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 US claimed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN ENPP2, TPX2, TPD52L2 ALDH1A1 4584/4885MAPK1 3988/4885POLB 3834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.